Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries
Public ClinicalTrials.gov record NCT04572906. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2a, Multicenter, Randomized, Patient and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to SOC in the Treatment of Acute Single Transected Peripheral Nerve Injury Occurring Below the Distal Border of the Brachial Plexus Requiring Surgical Repair.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 16 and 80 years of age.
Study identification
- NCT ID
- NCT04572906
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 25, 2020 (Actual)
- Primary completion
- Jun 27, 2024 (Actual)
- Completion
- Jun 27, 2024 (Actual)
- Last update posted
- Oct 15, 2026
2020 – 2024
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UF Health - University of FL - Gainesville | Gainesville | Florida | 32607 | — |
| Orlando Health | Orlando | Florida | 32806 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Indiana Hand to Shoulder Center | Indianapolis | Indiana | 46260 | — |
| Curtis National Hand Center | Baltimore | Maryland | 21218 | — |
| Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| The Ohio State University Wexner Medical Center Hand and Upper Extremity Center | Columbus | Ohio | 43202 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23398 | — |
| Harborview Medical Center | Seattle | Washington | 98107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04572906, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2026 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04572906 live on ClinicalTrials.gov.